The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

Area of Science:

• Cell Biology
• Molecular Biology
• Genetics

Background:

• Eukaryotic cells activate cell cycle checkpoints in response to ionizing radiation (IR).
• Defects in IR-induced S-phase checkpoints lead to radioresistant DNA synthesis, observed in ataxia-telangiectasia patients with ATM gene mutations.
• Cdc25A phosphatase activates cyclin-dependent kinase 2 (Cdk2) for DNA synthesis but is degraded upon DNA damage or replication stress.

Purpose of the Study:

• To investigate the functional link between ATM, Chk2, and Cdc25A in controlling the S-phase checkpoint.
• To elucidate the mechanism by which ionizing radiation induces Cdc25A degradation.
• To determine the role of the ATM-Chk2-Cdc25A-Cdk2 pathway in preventing radioresistant DNA synthesis.

Main Methods:

• Investigated the role of ATM and Chk2 in ionizing radiation-induced Cdc25A degradation.
• Analyzed the phosphorylation of Cdc25A on serine 123 by Chk2.
• Utilized cancer-prone patient cell lines and tumor-associated Chk2 alleles to assess pathway function.

Main Results:

• Ionizing radiation-induced Cdc25A destruction requires ATM and Chk2-mediated phosphorylation of Cdc25A at serine 123.
• Loss of Cdc25A protein after IR prevents Cdk2 dephosphorylation, causing a transient DNA replication blockade.
• Tumor-associated Chk2 alleles, elevated Cdc25A, or Cdk2AF mutants impair the inhibition of DNA synthesis upon irradiation.

Conclusions:

• The ATM-Chk2-Cdc25A-Cdk2 pathway acts as a genomic integrity checkpoint.
• This pathway prevents radioresistant DNA synthesis.
• Chk2 is identified as a potential tumor suppressor due to its role in this checkpoint.